Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02296112
Title Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center
Indications

melanoma

Therapies

Trametinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field